DEDI.ST(DEDI.ST)
DEDI.ST
Dedicare AB is a Nordic healthcare staffing specialist providing temporary physicians, nurses, and allied health professionals primarily to Swedish public hospitals and healthcare facilities. The company operates through direct placement and consultancy models, competing on quality of medical professionals and regulatory compliance in a fragmented market. Recent performance reflects post-pandemic normalization with declining demand for temporary healthcare staff as Swedish regions reduce outsourcing budgets.
Dedicare charges hourly or daily rates for temporary medical staff placements, capturing spread between what they pay healthcare professionals and what they bill to hospitals. Gross margins of 2.1% indicate a high-volume, low-margin model typical of Scandinavian staffing where labor costs dominate (97-98% of revenue). Pricing power is limited by public sector budget constraints and competitive bidding processes. The company maintains profitability through operational efficiency, database of pre-vetted professionals, and regulatory expertise in Swedish healthcare licensing. Operating leverage is moderate - fixed costs include recruiter salaries and compliance infrastructure, but variable costs (contractor wages) scale directly with revenue.
Swedish regional healthcare budget allocations and outsourcing policies - public sector represents 80%+ of demand
Temporary staffing utilization rates in Nordic hospitals - driven by permanent staff shortages and sick leave patterns
Gross margin trends reflecting pricing pressure from public tenders versus wage inflation for medical professionals
Market share gains/losses versus competitors like Barona Healthcare, Medpeople, and internal hospital staffing pools
Swedish healthcare policy shift toward reducing temporary staffing dependency - government initiatives to increase permanent hospital staff could structurally reduce market size by 20-30% over 5-10 years
Regulatory changes to maximum billing rates or working conditions for temporary medical staff - Swedish regions periodically implement rate caps to control costs
Digital health and telemedicine reducing need for physical temporary staff placements in certain specialties
Intense competition from regional players and hospital internal staffing pools - limited differentiation beyond regulatory compliance and database quality
Wage inflation for medical professionals outpacing ability to raise billing rates to public sector clients - margin compression risk in tight labor markets
Consolidation among competitors creating larger players with better economies of scale in recruitment and compliance
Working capital volatility - receivables from regional governments can extend during budget constraints, stressing cash flow despite low debt
Modest leverage (0.29 D/E) provides limited concern, but thin margins (2.3% net) mean small revenue declines significantly impact absolute profitability
moderate - Healthcare staffing is relatively defensive as medical services are non-discretionary, but demand for temporary staff is cyclical based on regional government budgets. Economic downturns pressure Swedish municipal finances, leading to outsourcing budget cuts as seen in 2025-2026. However, structural shortages of medical professionals provide baseline demand. GDP growth correlates moderately with tax revenues funding regional healthcare budgets.
Low direct sensitivity - minimal debt (0.29 D/E) means financing costs are not material. Indirect impact through Swedish government finances: rising rates increase regional borrowing costs, potentially constraining healthcare outsourcing budgets. Valuation multiples compress modestly with rising rates given the defensive nature and high FCF yield (16.9%), but less sensitive than growth stocks.
Minimal - customers are primarily Swedish regional governments with negligible default risk. Working capital requirements are moderate (1.40 current ratio) with receivables from public entities typically paid within 30-60 days. No meaningful exposure to corporate credit conditions or consumer lending.
value - Stock trades at 0.3x P/S and 5.5x EV/EBITDA with 16.9% FCF yield, attracting deep value investors despite negative momentum. High ROE (11.4%) and ROA (8.2%) relative to market cap suggest operational efficiency. Recent 21% decline creates contrarian opportunity if Swedish healthcare outsourcing stabilizes. Not suitable for growth investors given -15% revenue decline and structural headwinds.
moderate-to-high - Small cap ($0.4B) with limited liquidity in Swedish market creates volatility. Stock highly sensitive to quarterly earnings surprises given thin margins where small revenue misses significantly impact profitability. Recent 6-month decline of 19% reflects elevated volatility during sector downturn. Beta likely 1.2-1.5x relative to OMX Stockholm Small Cap index.